A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis
Phase of Trial: Phase III
Latest Information Update: 28 Mar 2013
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms PEARL
- Sponsors Centocor
- 01 Sep 2011 Results published in the Journal of Dermatological Science.
- 16 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2009 Planned end date changed from 1 Apr 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.